IRCT20111121008146N39 IRCT 2022-08-02 Shahid Beheshti University of Medical Sciences Evaluating the Effect of Intravenous Laser and Comparison of Laser Treatment Effect with Red and Blue Wavelengths in the Treatment of Patients with Covid-19 Evaluating the Effect of Intravenous Laser and Comparison of Laser Treatment Effect with Red and Blue Wavelengths in the Treatment of Patients with Covid-19 2021-08-23 anticipated 60 Complete https://irct.ir/trial/52052 interventional Randomization: Not randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Blinding description: The data analyst was blinded to the grouping of the data. Grouping based on the definition of codes such as A, B, C or 1, 2, and 3 will be provided to the data analyst, and the analyst does not know how to assign these codes to which treatment group. N/A COVID-19 (Coronavirus Disease 2019). Intervention 1: Two case groups: The treatment procedure with a low-power gallium arsenide 660 nm laser diode with an output dose of 2 joules per square centimeter, continuous for 7 minutes 5 sessions daily under intravenous laser. The same dose of laser with equal time of the first group with low power laser diode laser with a wavelength of 450 nm is prescribed to patients in the case of blue laser. Intervention 2: Control group: Patients will receive the current standard of care for COVID-19. Yes - There is a plan to make this available What will be shared: All data is potentially shareable after unidentified individuals When: Access period starts 6 months after the results are published To whom: Researchers and doctors Conditions: Email the corresponding author and earn permission Where to obtain: Email the corresponding author How to obtain: Email the corresponding author, the authors' meeting, send the data at your discretion Comments: